Jubilant Organosys has acquired 100 per cent stake in Speciality Molecules Pvt. Ltd for Rs 199.5 million on a debt free, cash free basis.
Jubilant Organosys Ltd., an integrated pharmaceutical company, which is, also the largest custom research and manufacturing services has acquired Speciality Molecules Pvt. Ltd., a niche manufacturer of Speciality Intermediates with manufacturing facilities located in Ambernath, near Mumbai. The purchase consideration to acquire 100 per cent stake is Rs 199.5 million on a debt free, cash free basis.
The acquired company is engaged in the business of developing, manufacturing and selling of specialty intermediates, which include primarily pyridine derivatives that are used in pharmaceuticals and other life science industry. The acquisition will be accretive to Jubilant's earnings from the date of acquisition and will strengthen Jubilant's ability to provide comprehensive offering of pyridine derivatives to the customers in life science industry.
The company has a presence across the pharmaceutical value chain for products and services such as exclusive synthesis, contract manufacturing, proprietary products, active pharmaceutical ingredients, generic dosage forms, drug discovery services, drug development services, chemistry services and clinical research services. It has geographically diversified manufacturing facilities in eight locations: Gajraula (UP), Nanjangud (Karnataka), Roorkee (Uttarakhand), Nira (Maharashtra), Udaipur (Rajasthan), Samlaya (Gujarat).